mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.6 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.6 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.6 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |